Clinical trial
Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly…
NCT00291655 · UCB Pharma, Industry · Completed
Key facts
| NCT number | NCT00291655 |
|---|---|
| Title | Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903). |
| Official title | A Multicenter, Open-label, Follow-up Trial Evaluating the Long-term Safety of Levetiracetam, for Patients Suffering From Epilepsy and Coming From the Study N01175 (NCT00175903). |
| Lead sponsor | UCB Pharma, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy |
| Intervention type | Drug |
| Interventions | Levetiracetam |
| Enrollment | 130 |
| Start date | Jun 1, 2006 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Feb 14, 2006 |
| Last update posted | May 18, 2015 |
| Countries | Belgium, Bulgaria, Finland, France, Poland, Switzerland |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: